Colgate-Palmolive (NYSE:CL) Price Target Lowered to $77.00 at Barclays

Colgate-Palmolive (NYSE:CL – Get Rating) had its price target reduced by Barclays from $80.00 to $77.00 in a research report sent to investors on Tuesday, The Fly reports. They currently have an equal weight rating on the stock.

Several other analysts have also recently weighed in on the company. Deutsche Bank Aktiengesellschaft dropped their price target on Colgate-Palmolive from $87.00 to $84.00 in a report on Monday, January 30th. Morgan Stanley raised Colgate-Palmolive from an equal weight rating to an overweight rating and set a $82.00 price objective for the company in a report on Monday, January 30th. JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $81.00 to $86.00 and gave the company an overweight rating in a report on Friday, January 13th. The Goldman Sachs Group dropped their price objective on Colgate-Palmolive from $91.00 to $81.00 and set a buy rating for the company in a report on Monday, October 10th. Finally, Credit Suisse Group dropped their price objective on Colgate-Palmolive from $88.00 to $85.00 and set an outperform rating for the company in a report on Tuesday, October 18th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of Moderate Buy and a consensus price target of $81.90.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $74.29 on Tuesday. The company has a current ratio of 0.40, a quick ratio of 0.24 and a debt-to-equity ratio of 7.81. Colgate-Palmolive has a 12 month low of $67.84 and a 12 month high of $83.81. The stock has a 50 day moving average of $77.42 and a 200-day moving average of $76.53. The company has a market capitalization of $62.05 billion, a P/E ratio of 34.88, a P/E/G ratio of 3.89 and a beta of 0.50.

Colgate-Palmolive (NYSE:CL – Get Rating) last issued its earnings results on Friday, January 27th. The company reported $0.77 EPS for the quarter, hitting the consensus estimate of $0.77. The company had revenue of $4.63 billion during the quarter, compared to the consensus estimate of $4.58 billion. Colgate-Palmolive had a return on equity of 317.08% and a net margin of 9.93%. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.79 EPS. As a group, equities research analysts predict that Colgate-Palmolive will post 3.1 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 14th. Investors of record on Monday, January 23rd will be given a dividend of $0.47 per share. The ex-dividend date is Friday, January 20th. This represents a $1.88 dividend on an annualized basis and a yield of 2.53%. Colgate-Palmolive’s dividend payout ratio is currently 88.26%.

Institutional Investors Weigh In On Colgate-Palmolive

A number of hedge funds and other institutional investors have recently bought and sold shares of CL. Dimensional Fund Advisors LP grew its position in Colgate-Palmolive by 4.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock worth $185,376,000 after acquiring an additional 94,837 shares during the last quarter. Covestor Ltd grew its position in Colgate-Palmolive by 71.9% during the 1st quarter. Covestor Ltd now owns 2,451 shares of the company’s stock worth $186,000 after acquiring an additional 1,025 shares during the last quarter. Mackenzie Financial Corp grew its position in Colgate-Palmolive by 8.5% during the 1st quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock worth $142,774,000 after acquiring an additional 146,936 shares during the last quarter. First Western Trust Bank bought a new stake in shares of Colgate-Palmolive in the 1st quarter valued at about $569,000. Finally, Wsfs Capital Management LLC bought a new stake in shares of Colgate-Palmolive in the 1st quarter valued at about $288,000. Institutional investors own 77.63% of the company’s stock.

About Colgate-Palmolive

(Get Rating)

Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.